KalVista Pharmaceuticals (KALV) Earnings Date, Estimates & Call Transcripts $12.02 +0.07 (+0.59%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$12.02 +0.01 (+0.04%) As of 04/15/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KalVista Pharmaceuticals Earnings Summary Latest Q2 Earnings DateDec. 5EstimatedConsensus EPS (Dec. 5) -$0.92 Actual EPS (Dec. 5) -$0.91 Beat By $0.01 KalVista Pharmaceuticals released Q2 2025 earnings on December 5, 2024, reporting an EPS of -$0.91, which topped analysts' consensus estimates of -$0.92 by $0.01. With a trailing EPS of -$3.72, KalVista Pharmaceuticals' earnings are expected to grow next year, from ($3.56) to ($2.90) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get KalVista Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on KalVista Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataKALV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads KalVista Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.90-$0.72-$0.81Q2 20252-$0.91-$0.71-$0.81Q3 20252-$0.89$0.81-$0.04Q4 20252-$0.84-$0.77-$0.81FY 20258-$3.54-$1.39-$2.47Q1 20261-$0.72-$0.72-$0.72Q2 20261-$0.60-$0.60-$0.60Q3 20261-$0.53-$0.53-$0.53Q4 20261-$0.47-$0.47-$0.47FY 20264($2.32)($2.32)($2.32) Remove Ads KalVista Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails12/5/2024Q2 2025-$0.92-$0.91+$0.01-$0.91--9/5/2024Q1 2025-$0.91-$0.87+$0.04-$0.87--7/11/2024Q4 2024-$0.73-$1.02 -$0.29-$1.02--3/11/2024Q3 2024-$0.75-$0.84 -$0.09-$0.84--12/7/2023Q2 2024-$0.76-$0.80 -$0.04-$0.80--9/7/2023Q1 2024-$0.86-$0.74+$0.12-$0.74--7/7/2023Q4 2023-$0.87-$0.77+$0.10-$0.77-- KalVista Pharmaceuticals Earnings - Frequently Asked Questions When did KalVista Pharmaceuticals announce their last quarterly earnings? KalVista Pharmaceuticals (NASDAQ:KALV) last announced its quarterly earning data on Thursday, December 5, 2024. Learn more on KALV's earnings history. Did KalVista Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, KalVista Pharmaceuticals (NASDAQ:KALV) reported ($0.91) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.92) by $0.01. Learn more on analysts' earnings estimate vs. KALV's actual earnings. How much profit does KalVista Pharmaceuticals generate each year? KalVista Pharmaceuticals (NASDAQ:KALV) has a recorded net income of -$126.64 million. KALV has generated -$3.72 earnings per share over the last four quarters. What is KalVista Pharmaceuticals's EPS forecast for next year? KalVista Pharmaceuticals's earnings are expected to grow from ($3.56) per share to ($2.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies AMRX Earnings Results MLTX Earnings Results TWST Earnings Results MIRM Earnings Results VCEL Earnings Results BHC Earnings Results BHVN Earnings Results TARS Earnings Results BLTE Earnings Results NAMS Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:KALV) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KALV Stock Free KALV Stock Alerts